These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23830193)

  • 41. Rectal dose reduction with IMRT for prostate radiotherapy.
    Hardcastle N; Davies A; Foo K; Miller A; Metcalfe PE
    J Med Imaging Radiat Oncol; 2010 Jun; 54(3):235-48. PubMed ID: 20598012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy.
    De Meerleer G; Villeirs G; Bral S; Paelinck L; De Gersem W; Dekuyper P; De Neve W
    Radiother Oncol; 2005 Jun; 75(3):325-33. PubMed ID: 15967524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
    Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Models for predicting objective function weights in prostate cancer IMRT.
    Boutilier JJ; Lee T; Craig T; Sharpe MB; Chan TC
    Med Phys; 2015 Apr; 42(4):1586-95. PubMed ID: 25832049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy.
    Bauman G; Gete E; Chen JZ; Wong E
    Med Dosim; 2004; 29(1):18-25. PubMed ID: 15023389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient geometry-driven information retrieval for IMRT treatment plan quality control.
    Wu B; Ricchetti F; Sanguineti G; Kazhdan M; Simari P; Chuang M; Taylor R; Jacques R; McNutt T
    Med Phys; 2009 Dec; 36(12):5497-505. PubMed ID: 20095262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maximizing dosimetric benefits of IMRT in the treatment of localized prostate cancer through multicriteria optimization planning.
    Wala J; Craft D; Paly J; Zietman A; Efstathiou J
    Med Dosim; 2013; 38(3):298-303. PubMed ID: 23540492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automatic IMRT planning via static field fluence prediction (AIP-SFFP): a deep learning algorithm for real-time prostate treatment planning.
    Li X; Zhang J; Sheng Y; Chang Y; Yin FF; Ge Y; Wu QJ; Wang C
    Phys Med Biol; 2020 Sep; 65(17):175014. PubMed ID: 32663813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A global quality assurance system for personalized radiation therapy treatment planning for the prostate (or other sites).
    Nwankwo O; Sihono DS; Schneider F; Wenz F
    Phys Med Biol; 2014 Sep; 59(18):5575-91. PubMed ID: 25171108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A simple algorithm to predict non-compliance with organ at risk dose-volume constraints when planning intensity modulated post-prostatectomy radiation treatment: 'Why we should put the CART before the horse'.
    Collier N; Kneebone A; Hruby G; McCloud P; Booth J; Eade T
    J Med Imaging Radiat Oncol; 2019 Aug; 63(4):546-551. PubMed ID: 31136089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can knowledge-based DVH predictions be used for automated, individualized quality assurance of radiotherapy treatment plans?
    Tol JP; Dahele M; Delaney AR; Slotman BJ; Verbakel WF
    Radiat Oncol; 2015 Nov; 10():234. PubMed ID: 26584574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer.
    Guckenberger M; Pohl F; Baier K; Meyer J; Vordermark D; Flentje M
    Radiother Oncol; 2006 Apr; 79(1):59-64. PubMed ID: 16584794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using individual patient anatomy to predict protocol compliance for prostate intensity-modulated radiotherapy.
    Caine H; Whalley D; Kneebone A; McCloud P; Eade T
    Med Dosim; 2016; 41(1):70-4. PubMed ID: 26755075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective clinical validation of independent DVH prediction for plan QA in automatic treatment planning for prostate cancer patients.
    Wang Y; Heijmen BJM; Petit SF
    Radiother Oncol; 2017 Dec; 125(3):500-506. PubMed ID: 29061497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive performance of an OVH-based treatment planning quality assurance model for prostate VMAT: Assessing dependence on training cohort size and composition.
    Burton A; Norvill C; Ebert MA
    Med Dosim; 2019 Winter; 44(4):315-323. PubMed ID: 30522800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results.
    van den Ende RPJ; Peters FP; Harderwijk E; Rütten H; Bouwmans L; Berbee M; Canters RAM; Stoian G; Compagner K; Rozema T; de Smet M; Intven MPW; Tijssen RHN; Theuws J; van Haaren P; van Triest B; Eekhout D; Marijnen CAM; van der Heide UA; Kerkhof EM
    Radiat Oncol; 2020 Feb; 15(1):41. PubMed ID: 32070386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knowledge-based prediction of three-dimensional dose distributions for external beam radiotherapy.
    Shiraishi S; Moore KL
    Med Phys; 2016 Jan; 43(1):378. PubMed ID: 26745931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantifying cell migration distance as a contributing factor to the development of rectal toxicity after prostate radiotherapy.
    Munbodh R; Jackson A
    Med Phys; 2014 Feb; 41(2):021724. PubMed ID: 24506615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plan quality improvement by DVH sharing and planner's experience: Results of a SBRT multicentric planning study on prostate.
    Villaggi E; Hernandez V; Fusella M; Moretti E; Russo S; Vaccara EML; Nardiello B; Esposito M; Saez J; Cilla S; Marino C; Stasi M; Mancosu P
    Phys Med; 2019 Jun; 62():73-82. PubMed ID: 31153401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved robotic stereotactic body radiation therapy plan quality and planning efficacy for organ-confined prostate cancer utilizing overlap-volume histogram-driven planning methodology.
    Wu B; Pang D; Lei S; Gatti J; Tong M; McNutt T; Kole T; Dritschilo A; Collins S
    Radiother Oncol; 2014 Aug; 112(2):221-6. PubMed ID: 25108808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.